Antigua and Barbuda vs Saint Lucia: Immunization, Hib3
Antigua and Barbuda
99.0%
in 2024
Saint Lucia
99.0%
in 2024
Antigua and Barbuda rank
1st
Saint Lucia rank
1st
Immunization, Hib3 over time
- Antigua and Barbuda
- Saint Lucia
How they compare
Antigua and Barbuda currently reports 99.0% against 99.0% in Saint Lucia, a difference of 0.0%.
The two have swapped places 9 times across 23 shared years of data; in 2002 it was Antigua and Barbuda ahead.
Antigua and Barbuda ranks 1st and Saint Lucia ranks 1st of 191 countries.
Antigua and Barbuda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Saint Lucia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.4% | 82.4% | 15.0% | Antigua and Barbuda |
| 2010s | 97.3% | 95.3% | 2.0% | Antigua and Barbuda |
| 2020s | 97.4% | 84.0% | 13.4% | Antigua and Barbuda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Antigua and Barbuda or Saint Lucia?
- Antigua and Barbuda, at 99.0% against 99.0% in Saint Lucia as of 2024.
- What is the difference in immunization, hib3 between Antigua and Barbuda and Saint Lucia?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Saint Lucia?
- 23 years are reported by both, from 2002 to 2024.
- How do Antigua and Barbuda and Saint Lucia rank globally for immunization, hib3?
- Antigua and Barbuda ranks 1st and Saint Lucia ranks 1st of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.